ProfessorTriciaTan

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Chair in Metabolic Medicine and Endocrinology

Contact

+44 (0)20 3313 8038t.tan

Location

6N6ECommonwealth BuildingHammersmith Campus

Summary

Dr Tricia Tan is a Consultant in Diabetes, Endocrinology and Metabolic Medicine at Imperial College London and NHS Trust. She possesses over 10 years’ experience in gut hormone research and physiological studies into the impact of gut hormones on weight and T2DM. She has completed several Phase I trials on the gut hormone analogues, which are being developed for the treatment of obesity. She is the director of the SAS Gut Hormone service, and her clinical research spans a wide gamut from the diagnosis and treatment of neuroendocrine tumours to diagnostic testing in Endocrine disorders.

Publications

Journals

Bally L, Khoo B, Knop F, et al.Bally L, Khoo B, Knop F, Madsbad S, Patti M-E, Tan T close, 2023, Call for prospective studies of continuous glucose monitoring to define the glycaemic response to bariatric surgery, The Lancet Diabetes & Endocrinology, Vol:11, ISSN:2213-8587, Pages:712-714

Eng P, Forlano R, Tan T, et al.Eng P, Forlano R, Tan T, Manousou P, Dhillo W, Izzi-Engbeaya C close, 2023, Non-alcoholic fatty liver disease in women – current knowledge and emerging concepts, Jhep Reports, Vol:5, ISSN:2589-5559

Lagou V, Jiang L, Ulrich A, et al.Lagou V, Jiang L, Ulrich A, Zudina L, González KSG, Balkhiyarova Z, Faggian A, Maina JG, Chen S, Todorov PV, Sharapov S, David A, Marullo L, Mägi R, Rujan R-M, Ahlqvist E, Thorleifsson G, Gao Η, Εvangelou Ε, Benyamin B, Scott RA, Isaacs A, Zhao JH, Willems SM, Johnson T, Gieger C, Grallert H, Meisinger C, Müller-Nurasyid M, Strawbridge RJ, Goel A, Rybin D, Albrecht E, Jackson AU, Stringham HM, Corrêa IR, Farber-Eger E, Steinthorsdottir V, Uitterlinden AG, Munroe PB, Brown MJ, Schmidberger J, Holmen O, Thorand B, Hveem K, Wilsgaard T, Mohlke KL, Wang Z, GWA-PA Consortium, Shmeliov A, den Hoed M, Loos RJF, Kratzer W, Haenle M, Koenig W, Boehm BO, Tan TM, Tomas A, Salem V, Barroso I, Tuomilehto J, Boehnke M, Florez JC, Hamsten A, Watkins H, Njølstad I, Wichmann H-E, Caulfield MJ, Khaw K-T, van Duijn CM, Hofman A, Wareham NJ, Langenberg C, Whitfield JB, Martin NG, Montgomery G, Scapoli C, Tzoulaki I, Elliott P, Thorsteinsdottir U, Stefansson K, Brittain EL, McCarthy MI, Froguel P, Sexton PM, Wootten D, Groop L, Dupuis J, Meigs JB, Deganutti G, Demirkan A, Pers TH, Reynolds CA, Aulchenko YS, Kaakinen MA, Jones B, Prokopenko I, Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC) close, 2023, GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification, Nature Genetics, Vol:55, ISSN:1061-4036, Pages:1448-1461

Kowalka AM, Alexiadou K, Cuenco J, et al.Kowalka AM, Alexiadou K, Cuenco J, Clarke REE, Minnion J, Williams ELL, Bech P, Purkayastha S, Ahmed ARR, Takats Z, Whitwell HJJ, Romero MG, Bloom SRR, Camuzeaux S, Lewis MRR, Khoo B, Tan TM-M close, 2023, The postprandial secretion of peptide YY1-36 and 3-36 in obesity is differentially increased after gastric bypass versus sleeve gastrectomy, Clinical Endocrinology, Vol:99, ISSN:0300-0664, Pages:272-284

Patel P, Thomas R, Hamady M, et al.Patel P, Thomas R, Hamady M, Hague J, Raja J, Tan T, Bloom S, Richards T, Weiss CR, Prechtl CG, Smith C, Sasikaran T, Hesketh R, Bourmpaki E, Johnson NA, Fiorentino F, Ahmed AR close, 2023, EMBIO trial study protocol: left gastric artery embolisation for weight loss in patients living with obesity with a BMI 35-50 kg/m2, Bmj Open, Vol:13, ISSN:2044-6055

More Publications